Furthermore, the specific impact of basophil and serum cholinesterase on the clinical course and outcomes of patients affected by IgG4-RD and renal involvement remains undetermined, highlighting the necessity for further investigation. This evidence concerns the gene BCHE and immunoglobulin G4-related sclerosing disease.